News

Prior to joining PPD, Hill worked with IMS Health as the president of IMS Consulting Group. Before IMS, Hill served as the senior vice president for Acumen Sciences.

Curaxins are synthetic small molecules intended to simultaneously target major cell stress response pathways that are frequently deregulated in cancer. Incuron CEO Andrei Leonov said this prestigious Skolkovo

The combined company is expected to have a diversified revenue base from 12 products currently marketed in the US in the CNS and women’s health areas. Following the

The approval has been granted for 100mg/ml and 150mg/ml strengths. Enoxaparin Sodium Injection is the generic version of Lovenox of Sanofi-aventis and is indicated for the treatment of

Produced by Lincoln, Anapen is indicated as a treatment for anaphylactic shock. Under the five year agreement, Allergy has paid £600,000 to Lincoln. Allergy is selling Anapen in

NDV-3 is a prophylactic vaccine candidate which contains a recombinant Candida surface protein, Als3, and an adjuvant Alhydrogel. The study is designed to assess the efficacy of the

The company has started the European Phase III trials of ATX-101 in 2010 in collaboration with Intendis, Bayer HealthCare’s dermatology unit, which has licensed rights to ATX-101 outside

The trial aims to investigate the safety, tolerability and antiviral activity of INX-189 in conjunction with pegylated interferon and ribavirin in chronic HCV-infected genotype 2 and 3 treatment

The trial aims to evaluate the safety, tolerability and pharmacokinetics of PRC-4016 in healthy volunteers. Pronova CEO Morten Jurs said they believe PRC-4016 has an optimal profile to